|
 COSTA
MESA, California - March 15, 2002 - IOP Inc., the premier
developer and distributor of specialty devices for surgery,
has launched yet another unique oculoplastic surgical technology.
The Osmed™ Hydrogel Expander technology, a new advancement
in tissue expansion, will be used by oculoplastic surgeons
for the treatment of Congenital Microphthalmos/Anophthalmos.
The Osmed™ has a distinctive advantage over the application
of incremental sized conformers. The expanding hydrogel is
capable of achieving expansion within weeks rather than months,
giving the ocularist the ability to fit a cosmetic prosthesis
much earlier. This new therapy has been described by clinicians
as "one of the most promising innovations in tissue expansion."
"We are pleased to introduce this new innovation for
Anophthalmos and Microphthalmos cases." said Jason Malecka,
President of IOP Inc. "This technology provides doctors
with another option to make an impact on these rare and complicated
cases."
The Osmed™ Hydrogel Tissue Expander is available as
a sphere in three sizes - 2.0 ml, 3.0 ml and 4.0 ml.
IOP, Inc. is committed to improving the quality of life of
people worldwide….to elevating surgical performance through
ideas, innovation and technology.
Media Contact:
media@iopinc.com
Back to Recent News
|
